PPD names chief scientific officer of BioDuro

Wednesday, August 17, 2011 11:43 AM

PPD has named Jasmine (Jisong) Cui, Ph.D., chief scientific officer of BioDuro, a PPD Company. Cui will provide scientific leadership to BioDuro's integrated drug discovery services across a range of disease areas and expand its use of novel technologies for small and large molecules and in stem cells and imaging.

Cui previously served as vice president and head of drug discovery and translation for a newly established biotech company where she provided leadership for project portfolio and operations from preclinical to phase II clinical studies. Prior to that role, she spent 14 years at Merck Research Laboratories.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs